Dr. Anirudh Acharya and Dr. Nien-Pei Tsai study mitochondrial function in a Fragile X syndrome research laboratory.

Pharmacological Activation of PGC-1α to Treat Fragile X Syndrome

Dr. Tsai and Dr. Acharya are testing whether boosting mitochondrial function can improve key Fragile X syndrome features in a mouse model and inform treatment strategies.

Read More »

Pharmacologically Activating mGluR7 as a Novel Therapy for Fragile X Syndrome

Join Dr. Tsai and Dr. Kumar on a journey into novel treatments for Fragile X syndrome. Activating mGluR7 could be a game-changer, opening up uncharted therapeutic territory.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (45)